{
    "doi": "https://doi.org/10.1182/blood.V104.11.4729.4729",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=4",
    "start_url_page_num": 4,
    "is_scraped": "1",
    "article_title": "Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-\u03b1. ",
    "article_date": "November 16, 2004",
    "session_type": "Abstracts Not Selected for Presentation",
    "topics": [
        "myelodysplastic syndrome",
        "tocopherols",
        "tretinoin",
        "vitamin e",
        "transfusion",
        "refractory anemias",
        "adverse effects",
        "adverse event",
        "alopecia",
        "anemia"
    ],
    "author_names": [
        "Aristoteles A.N. Giagounidis, MD",
        "Sabine Haase",
        "Ulrich Germing, MD, PhD",
        "Claudia Schoch, MD, PhD",
        "Brigitte Schlegelberger, PhD",
        "Ludwig Wilkens, PhD",
        "Guntram Bu\u0308sche, MD",
        "Hans H. Kreipe, MD, PhD",
        "Manuel Aivado, MD",
        "Michael Lu\u0308bbert, MD, PhD",
        "Arnold Ganser, MD, PhD",
        "Carlo Aul, MD, PhD"
    ],
    "author_affiliations": [
        [
            "Medizinische Klinik II, St. Johannes Hospital, Duisburg, Germany"
        ],
        [
            "Medizinische Klinik II, St. Johannes Hospital, Duisburg, Germany"
        ],
        [
            "Klinik fu\u0308r Ha\u0308matologie, Onkologie und klinische Immunologie, Heinrich-Heine-Universita\u0308t, Du\u0308sseldorf, Germany"
        ],
        [
            "Medizinische Klinik III, Ludwig-Maximilians-Universita\u0308t, Mu\u0308nchen, Germany"
        ],
        [
            "Institut fu\u0308r Zell-und Molekularpathologie, Medizinische Hochschule, Hannover, Germany"
        ],
        [
            "Institut fu\u0308r Zell-und Molekularpathologie, Medizinische Hochschule, Hannover, Germany"
        ],
        [
            "Institut fu\u0308r Pathologie, Medizinische Hochschule, Hannover, Germany"
        ],
        [
            "Institut fu\u0308r Pathologie, Medizinische Hochschule, Hannover, Germany"
        ],
        [
            "Klinik fu\u0308r Ha\u0308matologie, Onkologie und klinische Immunologie, Heinrich-Heine-Universita\u0308t, Du\u0308sseldorf, Germany"
        ],
        [
            "Medizinische Klinik I, Albert-Ludwigs-Universita\u0308t, Freiburg, Germany"
        ],
        [
            "Abteilung fu\u0308r Ha\u0308matologie, Ha\u0308mostaseologie und Onkologie, Medizinische Hochschule, Hannover, Germany"
        ],
        [
            "Medizinische Klinik II, St. Johannes Hospital, Duisburg, Germany"
        ]
    ],
    "first_author_latitude": "51.45255254999999",
    "first_author_longitude": "6.736737199999999",
    "abstract_text": "All-trans-retinoic acid (ATRA) alone or in combination with cytokines and vitamins has shown erythroid remitting capacities in low-grade myelodysplastic syndromes (MDS). We performed a phase II study on 29 patients with MDS and isolated del(5q) including bands 5q31\u20135q33 to determine the efficacy and safety of ATRA in combination with tocopherol-\u03b1. All patients had low/intermediate-1 risk MDS according to the international prognostic scoring system. Inclusion criteria were isolated del(5q), medullary blast count of 50% of transfusion needs. No patient had a cytogenetic response. Responders did not show a reduction in del(5q) as determined in interphase fluorescence in-situ hybridization. There was no significant improvement in quality of life in responding patients as measured by the EORTC quality of life questionnaire. We conclude that the combination of ATRA and tocopherol-\u03b1 is not recommended for the treatment of del(5q) MDS."
}